FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Mexiletine 50mg capsules 84 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mexiletine 50mg capsules (Clinigen Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) 100 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mexiletine 50mg capsules (Clinigen Healthcare Ltd) 84 capsule 6 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clobetasol 500micrograms/g foam 100 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-codamol 15mg/500mg effervescent tablets sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Codipar 15mg/500mg effervescent tablets (Goldshield Pharmaceuticals Ltd) 100 tablet 4 x 25 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-codamol 15mg/500mg effervescent tablets sugar free (Accord Healthcare Ltd) 100 tablet 10 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Strontium ranelate 2g granules sachets sugar free (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Codipar 15mg/500mg effervescent tablets (Goldshield Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-codamol 15mg/500mg effervescent tablets sugar free 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Strontium ranelate 2g granules sachets sugar free (A A H Pharmaceuticals Ltd) 28 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-codamol 15mg/500mg effervescent tablets sugar free (Accord Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mitomycin 20mg powder and solvent for intravesical solution vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Neuropad neuropathy sweat detection pad (Ark Therapeutics Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gynokadin 0.06% gel (Imported (Germany)) 80 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oestraclin 0.06% gel (Imported (Spain)) 80 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxapram 100mg/5ml solution for injection ampoules (Synchrony Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oestraclin 0.06% gel (Imported (Spain)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gynokadin 0.06% gel (Imported (Germany)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxapram 100mg/5ml solution for injection ampoules (Synchrony Pharma Ltd) 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 10mg capsules (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 10mg capsules (Alliance Healthcare (Distribution) Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely colestyramine 4 gram/1 sachet powder for conventional release oral suspension (clinical drug) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Amarox Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Amarox Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Itraconazole 250mg/25ml solution for infusion ampoules and diluent VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bimatoprost 300micrograms/ml eye drops (Neon Healthcare Ltd) 3 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bimatoprost 300micrograms/ml eye drops (Neon Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Itraconazole 250mg/25ml solution for injection ampoules and diluent 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Itraconazole 250mg/25ml solution for infusion ampoules and diluent (Neon Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sporanox I.V. 250mg/25ml solution for injection ampoules and diluent (Janssen-Cilag Ltd) 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Itraconazole 250mg/25ml solution for infusion ampoules and diluent (Neon Healthcare Ltd) 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sporanox I.V. 250mg/25ml solution for injection ampoules and diluent (Janssen-Cilag Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Factor VIII 250unit / von Willebrand factor powder and solvent for solution for injection vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dried Factor VIII Fraction type 8Y 250unit powder and solvent for solution for injection vials (BPL (Bio Products laboratory)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Factor VIII 250unit / von Willebrand factor powder and solvent for solution for injection vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (Flynn Pharma Ltd) 30 tablet 2 x 15 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (Flynn Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Galpharm International Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Galpharm International Ltd) 7 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dried Factor VIII Fraction type 8Y 250unit powder and solvent for solution for injection vials (BPL (Bio Products laboratory)) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Galpharm International Ltd) 14 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules 7 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zanamivir 200mg/20ml solution for infusion vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dectova 200mg/20ml solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dectova 200mg/20ml solution for infusion vials (GlaxoSmithKline UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zanamivir 200mg/20ml solution for infusion vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nifedipine 5mg capsules (Alliance Healthcare (Distribution) Ltd) 90 capsule 9 x 10 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nifedipine 10mg capsules (Alliance Healthcare (Distribution) Ltd) 90 capsule 9 x 10 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zanamivir 200mg/20ml solution for infusion vials (GlaxoSmithKline UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zanamivir 200mg/20ml solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely glibenclamide 5 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely cefazolin (as cefazolin sodium) 1 gram/1 vial powder for conventional release solution for injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Evorel Sequi patches VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Balmonds Natural Shampoo & Body Wash VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Semi-Daonil 2.5mg tablets (Aventis Pharma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diabetamide 2.5mg tablets (Ashbourne Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (C P Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (A A H Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (IVAX Pharmaceuticals UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Viatris UK Healthcare Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Arrow Generics Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Phoenix Healthcare Distribution Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Daonil 5mg tablets (Aventis Pharma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diabetamide 5mg tablets (Ashbourne Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Kent Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Viatris UK Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Phoenix Healthcare Distribution Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Doncaster Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets 1000 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Approved Prescription Services) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Semi-Daonil 2.5mg tablets (Aventis Pharma) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Phoenix Healthcare Distribution Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Sigma Pharmaceuticals Plc) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Daonil 5mg tablets (Aventis Pharma) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Daonil 5mg tablets (PI) (Dowelhurst Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Euglucon 5mg tablets (Aventis Pharma) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Arrow Generics Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Almus Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (A A H Pharmaceuticals Ltd) 1000 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Approved Prescription Services) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Arrow Generics Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Doncaster Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Viatris UK Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Kent Pharma (UK) Ltd) 1000 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Phoenix Healthcare Distribution Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 6 of 86 Next End


This concept is not in any reference sets

Back to Start